EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Monitoring of physical activity and heart rate variability in patients with chronic heart failure using cardiac resynchronization devices



Monitoring of physical activity and heart rate variability in patients with chronic heart failure using cardiac resynchronization devices



American Journal of Cardiology 95(9): 1104-1107



Cardiac resynchronization therapy (CRT) devices not only deliver effective treatment but may also serve as valuable diagnostic tools in heart failure management. In the present study, the minutes of daily physical activity and heart rate variability, measured by sensors incorporated into such a device, reflected the effects of CRT and were related to New York Heart Association functional class. (c) 2005 by Excerpta Medica Inc.

(PDF emailed within 0-6 h: $19.90)

Accession: 012324826

Download citation: RISBibTeXText

PMID: 15842984

DOI: 10.1016/j.amjcard.2004.12.069



Related references

Effects of cardiac resynchronization therapy on heart rate variability in patients with chronic systolic heart failure and intraventricular conduction delay. American Journal of Cardiology 91(9): 1144-1147, 2003

Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. Journal of the American College of Cardiology 46(10): 1875-1882, 2005

Impact of QRS morphology on heart rate turbulence and heart rate variability after cardiac resynchronization therapy in patients with heart failure. European Review for Medical and Pharmacological Sciences 20(2): 317-322, 2016

Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 108(3): 266-269, 2003

Heart rate variability footprint New diagnostic tool to monitor the clinical benefit of cardiac resynchronization therapy in patients with end-stage heart failure. Journal of the American College of Cardiology 43(5 Supplement A): 126A, March 3, 2004

Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 110(16): 2389-2394, 2004

Persistent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients. Journal of Cardiovascular Electrophysiology 19(7): 693-701, 2008

Letter regarding article by Adamson et al, "Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device". Circulation 112(2): E37-8; Author Reply E37-8, 2005

Baseline heart rate variability predicts clinical events in heart failure patients implanted with cardiac resynchronization therapy: validation by means of related complexity index. Annals of Noninvasive Electrocardiology 15(4): 301-307, 2011

Variable effects of physical training of heart rate variability, heart rate recovery, and heart rate turbulence in chronic heart failure. Pacing and Clinical Electrophysiology 32 Suppl 1(): S113-S115, 2009

Increase in paced heart rate reduces muscle sympathetic nerve activity in heart failure patients treated with cardiac resynchronization therapy. Europace 17(3): 439-446, 2015

Biomarkers of inflammation in patients with chronic heart failure and implanted devices for cardiac resynchronization therapy. Kardiologiia 52(8): 38-43, 2012

Monitoring of heart rate variability in heart failure patients with cardiac resynchronisation therapy: interest of continuous and didactic algorithm. International Journal of Cardiology 144(1): 166-169, 2011

Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study. European Heart Journal 30(17): 2109-2116, 2010

Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training. European Heart Journal 16(10): 1380-1386, 1995